RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
8.31
+0.96 (13.06%)
At close: Aug 13, 2025, 4:00 PM
8.03
-0.28 (-3.37%)
Pre-market: Aug 14, 2025, 9:02 AM EDT
RxSight Revenue
RxSight had revenue of $33.64M in the quarter ending June 30, 2025, a decrease of -3.58%. This brings the company's revenue in the last twelve months to $147.06M, up 27.68% year-over-year. In the year 2024, RxSight had annual revenue of $139.93M with 57.09% growth.
Revenue (ttm)
$147.06M
Revenue Growth
+27.68%
P/S Ratio
2.28
Revenue / Employee
$295,299
Employees
498
Market Cap
340.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 139.93M | 50.85M | 57.09% |
| Dec 31, 2023 | 89.08M | 40.07M | 81.77% |
| Dec 31, 2022 | 49.01M | 26.41M | 116.90% |
| Dec 31, 2021 | 22.59M | 7.92M | 53.92% |
| Dec 31, 2020 | 14.68M | 12.44M | 554.98% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2006 | Pro | Pro | Pro |
| Dec 31, 2005 | Pro | Pro | Pro |
| Dec 31, 2004 | Pro | Pro | Pro |
| Dec 31, 2003 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
RXST News
- 17 hours ago - Shareholders who lost money on their RxSight, Inc. (NASDAQ: RXST) Investment Should Contact Wolf Haldenstein Immediately as the Lead Plaintiff Deadline is September 22nd - GlobeNewsWire
- 1 day ago - RXSIGHT STOCK: Lose Money on Your RxSight, Inc. (NASDAQ:RXST) Investment? Contact BFA Law before the September 22 Legal Deadline - GlobeNewsWire
- 3 days ago - RXST COURT NOTICE: RxSight, Inc. Investors may have been Affected by Fraud -- Contact BFA Law before September 22 if You Suffered Losses (NASDAQ:RXST) - GlobeNewsWire
- 3 days ago - RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST - PRNewsWire
- 5 days ago - RxSight, Inc. (RXST) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - RxSight, Inc. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 10 days ago - RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors - GlobeNewsWire
- 15 days ago - RXST INVESTORS: RxSight, Inc. (NASDAQ:RXST) Investors may have been Affected by Fraud – Contact BFA Law by September 22 about Potentially Recovering Losses - GlobeNewsWire